Molecule to Market: Inside the outsourcing space
174 episodes - English - Latest episode: 8 days ago -Molecule to Market takes you inside the contract outsourcing space with industry insights and thoughts direct from the brains of the people that make the headlines.
Talking everything from pharmaceutical contract research, development and manufacturing to clinical trial packaging, logistics and technology – Molecule to Market is a vital shot of infotainment for anyone who wants in on outsourcing.
Homepage Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Dan’s the man...at Custom Biologics
April 19, 2024 09:33 - 49 minutes - 114 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dan Mamelak, Founder & President at Custom Biologics. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Dan, covering: How reading The Billion-dollar Molecule book inspired him to explore a pathway into cutting-edge drug development The founding story of his company and some timeless advice not to burn bridges How the Canadian co...
Celebrating female talent in life sciences
April 05, 2024 12:23 - 20 minutes - 46.3 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with: Denise Bowser from Onyx Scientific Audrey Greenberg from SK Pharmteco Kendalle Burlin O’Connell from MassBio Elisabeth Stampa from Medicines For Europe Sabina Ouimet-Storrs from GHO Capital In this episode, we feature highlights from recent interviews with some of the most inspiring women in the life sciences industry. These women sat down with host, Raman Sehgal,...
The power of peptides
March 28, 2024 11:53 - 45 minutes - 105 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Alastair Hay, Vice President of Peptides at Almac Sciences. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Alastair, covering: The story behind Almac’s early bet of getting into the peptide game Behind the scenes of the incredible growth journey of Almac from a few hundred to 7000+ people... and some insight into the secret sau...
From Pfizer to CDMO carve-out
March 22, 2024 12:58 - 49 minutes - 114 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Brett Alderson, President and Site Leader of Novacina. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Brett, covering: The complexities of being on the inside of big pharma looking to carve out your site... then transitioning into a customer-facing CDMO Leaning into the freedom and liberation of having the shackles off as an in...
One-hour special: Meet the next big thing in obesity
March 15, 2024 13:17 - 1 hour - 153 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Arvid Söderhall, CEO at Empros Pharma. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Arvid, covering: The personal story of a pediatrician treating an obese child that led to the creation of Empros Pharma and its lead asset The 10-year journey from an idea to a successful Phase IIb trial... and what it felt like to reach the ...
M&A Roundtable and 2024 Predictions
March 08, 2024 10:34 - 57 minutes - 132 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with: Sabina Ouimet-Storrs, Principal at GHO Capital Partners James West, Managing Director at Lincoln International Derek Hennecke, investor and board member in biopharma and cell therapy manufacturing Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology ecosystem with his guests, covering: The year of the failed process in 2023... Which sub-segments o...
Transforming a family pharma firm
March 01, 2024 11:17 - 43 minutes - 99.3 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Elisabeth Stampa, President Medicines for Europe and Board Chair at Medichem. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Elisabeth, covering: She took the reigns of the family pharmaceutical firm from her father The struggle of turning around the business through rationalization and divestment and critical lessons learne...
From MassBio... to the world
February 23, 2024 13:20 - 55 minutes - 126 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kendalle Burlin O’Connell, CEO and President of MassBio. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kendalle, covering: The story behind how Massachusetts became one of the biggest biotech clusters in the world and why this ecosystem has such an energy Kendalle’s non-linear journey into MassBio and how she made an impact...
From banking to biotech
February 16, 2024 13:18 - 47 minutes - 108 MBFounder of the Center for Breakthrough Medicines - now part of SK Pharmteco. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Audrey, covering: How a career in real estate financial services led her to the world of cell & gene therapy The story of the creation of the Center for Breakthrough Medicines to its eventual sale and ‘fit’ with SK Pharmteco Why Philadelphia’s 'Cellicon Valley' is becoming one of the hottest life science clusters in the US...
Dealing with downturns... and the menopause.
February 09, 2024 10:47 - 47 minutes - 109 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Denise Bowser, Co-Founder and Commercial Director of Onyx Scientific. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Denise, covering: The founding story of Onyx and helping the company gain traction in the early years A lesson in M&A - being acquired as a great business and being allowed to thrive as a great business The non-...
The dealmaker now redefining commercialization
February 02, 2024 10:52 - 54 minutes - 125 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dominic (Nick) Marasco, Executive President and Chief Commercial Officer at Envision Pharma Group. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Nick, covering: Building businesses, learning lots, and selling BioAgilytix With many options on the table... what was it that attracted him to Envision Pharma Group The real-life be...
The biotech CDMO planning to impact the US
January 26, 2024 10:37 - 51 minutes - 118 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Himanshu Gadgil, CEO at Enzene Biosciences. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Himanshu, covering: How a personal tragedy led him from the US to India on a mission to make an impact Shifting from a technical to commercial focus to launch several biosimilars in India and beyond Being at the inception of a big pharm...
Molecule to Market: Our top trends 2023; part 2
January 19, 2024 12:10 - 22 minutes - 52.4 MBIn this special end-of-year episode, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who reflects on the 50+ episodes and special guest interviews throughout 2023. In the second part of our series on the top trends 2023, we dive deep into the dynamic and ever-evolving life sciences sector. From its various life cycles to the winds of change shaping the industry in 2024, there is a positive upturn on the horizon. In part two of t...
Outsourcing in Ontario - on the cusp of greatness
January 12, 2024 12:58 - 40 minutes - 93.1 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jason Field, President & CEO of Lifesciences Ontario. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jason, covering: How the combination of his scientific background and his passion for public policy made him a perfect fit for Lifesciences Ontario (LSO) How the pandemic acted as a wake-up call and catalyst to kickstarting a c...
Discover Diana of Dalriada
January 05, 2024 14:51 - 48 minutes - 111 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Diana Kraskouskaya, co-founder and CEO of Dalriada Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Diana, covering: Exactly what ‘the Toronto paradox’ is... How two, seed-funded failures, led to identifying a gap in the market along with access to a rich talent pool The challenges and realities of starting, growing and scaling ...
Molecule to Market: Our top trends 2023, part 1
December 29, 2023 12:22 - 25 minutes - 57.8 MBIn this special end-of-year episode, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who reflects on the 50+ episodes and special guest interviews throughout 2023. This special episode covers five key trends Raman identified including: The biotech slowdown in 2023 and how it affected the biotech sponsor space Covid rebalancing and the macro-factors that have affected the sector A continued focus on the life sciences supply c...
Expert to Entrepreneur
December 15, 2023 13:36 - 29 minutes - 66.6 MBIn this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jeffrey P. Kiplinger, Partner at Selling Science. Your host, Raman Sehgal, sits down with Jeff to discuss his new book, 'Expert to Entrepreneur'. Jeff Kiplinger is a PhD chemist who, after leaving a scientific leadership role at Pfizer in 1998, transitioned to business leadership and an entrepreneurial track. In 2007 he founded Averica Discovery, an analytical d...
The lab model of the future?
December 08, 2023 11:48 - 45 minutes - 103 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Clement Fourny, SVP of Commercial at SmartLabs. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Clement, covering: His journey of exploring options and opportunities, which led him to the life sciences space at just the right time Why modular labs and manufacturing suites as a service could provide a de-risked and cost-effective...
Look into 2024: Events Roundtable special
December 01, 2023 11:53 - 49 minutes - 114 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with: Manuel Leal, Corporate Marketing Director at Ardena. Eden Turner, Senior Conference Producer at Informa Connect Life Sciences Catherine Hunter, Senior Commercial Manager at ramarketing Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology outsourcing events space, covering: How industry events are experiencing record numbers in a post-pandemic wo...
The problem-solving CMC consultant
November 24, 2023 13:54 - 48 minutes - 111 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kevin Bittorf, Founder and Principal Consultant of SCxCMC. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kevin, covering: Joining a little company called Vertex Pharma when it was looking to be innovative The leap of faith required to become a consultant, and why helping smaller businesses makes a bigger difference An insight...
Microsoft talks to Molecule to Market
November 17, 2023 13:51 - 47 minutes - 109 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dr. Andi White, Head of Business Operations & Strategy for the Healthcare Industry Solutions Accelerator at Microsoft. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Andi, covering: How five years at GE helped develop and shape Andi into a leader Why having a broad mindset early on in your career will help you flourish down the...
Biopharma innovation in motion
November 10, 2023 12:15 - 47 minutes - 109 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Charles Ruban, CEO at Verdot. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Charles, covering: Crossing the border from supply chain to R&D, lessons learned from a technician turned business leader Creating the most extensive peanut allergy clinical trial in the world and opting for an IPO instead of a big pharma licensing dea...
Say hello to a “CTDMO”
November 03, 2023 10:46 - 45 minutes - 104 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dirk Lange, Head of Life Science Services at MilliporeSigma. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Dirk, covering: What he has learned from 25 years of bouncing around geographically in terms of cultural differences in understanding clients and colleagues Life on both sides of the fence as a drug sponsor and a CDMO, in...
The involuntary entrepreneur chemist
October 27, 2023 11:06 - 47 minutes - 108 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Fredrik Lehmann, Venture Partner at Industrifonden. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Fredrik, covering: How the closing of a business and customer requests led to a phoenix from the flames start-up opportunity His company's journey from inception and growth to eventual sale to Recipharm His transition to becoming...
A passion for pharma packaging
October 20, 2023 09:18 - 45 minutes - 105 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Peter Belden, President of Tjoapack US. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Peter, covering: How the success of a contract packaging operation led to a divestiture from AmerisourceBergen to PCI The fun, games, and complexities of multi-national, M&A integrations Smaller patient populations and personalized medicin...
M2M meets Moderna & CPHI Conversations
October 17, 2023 12:33 - 7 minutes - 17.5 MBIn this episode of Molecule to Market, tune in for a special announcement about where to find Molecule to Market host, Raman Sehgal, at CPHI Barcelona this month. Listen to the short episode covering: CDMO outlook - the trends and developments Raman expects to see this year and into 2024 A fireside chat with Moderna covering COVID-19 and Oncology Panel moderation on the topic - Why building a collaborative network is essential Are you heading to CPHI this month? Stop by one of Raman’s p...
Launching a technology-forward CDMO
October 13, 2023 12:48 - 48 minutes - 112 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Bruce Thompson, CEO of Kincell Bio. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Bruce, covering: The daunting and exciting prospect of launching a CDMO spin-out focused on early-phase companies The challenges and opportunities of pivoting a facility from innovator-owned to CDMO-owned Navigating from technical leader to a fi...
Designing facilities today for tomorrow’s medicines
October 06, 2023 10:20 - 47 minutes - 108 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gordon Nicholson, Director of the Life Sciences NEA at Exyte. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gordon, covering: Transitioning from a regular, technical role into a commercial lead in Asia Lessons from sport and going back to basics when breaking down silos at Novo Nordisk Engineering Tips for building a presence...
The problem-solving biopharma veteran
September 29, 2023 10:30 - 51 minutes - 117 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Matthew Stober, Chief Executive Officer at Abzena. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Matt, covering: How the failure of a big pharma R&D portfolio led to the creation of a CDMO business and a pipeline-ready facility Leadership lessons for transitioning from a functional leader to an enterprise-level one, and being ...
The servant leader creating the next generation CDMO
September 22, 2023 12:13 - 51 minutes - 119 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with J.D. Mowery, President and Chief Executive Officer at KBI Biopharma. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with J.D., covering: The experience of bringing a product to market... and then many years later seeing that product used on his wife to help bring his sons into the world How bringing a commercial facility online for ...
From Powdersize to Microsize
September 15, 2023 10:55 - 49 minutes - 113 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with TJ Higley, CEO at Microsize. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with TJ, covering: The fast, easy, scalable, precise, and non-patent-protected benefits of micronization How a synergistic capability alliance led to the eventual sale of his business to Lonza Capsugel The risks and realities of being an entrepreneur acquir...
The mission-driven biotech CEO
September 08, 2023 10:15 - 39 minutes - 89.6 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Howard Berman, CEO and Chairman of the Board at Coya Therapeutics Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Howard, covering: How a neurology appointment with his father led to the creation of a biotech company focused on neurodegenerative, autoimmune, and metabolic diseases Having the DNA of an entrepreneur but taking the...
Foot on the pedal for Predictive Oncology
September 01, 2023 10:26 - 44 minutes - 102 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Pamela Bush, Chief Business Officer at Predictive Oncology. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Pam, covering: The key aspects to successful deal-making learned over a decade with Eli Lily How a passion for curing cancer led Pamela to an opportunity to impact thousands of promising candidates directly How active mac...
One-hour special: The biopharma outsourcer
August 25, 2023 07:21 - 1 hour - 147 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tushar Misra, Chief Manufacturing Officer at Mersana Therapeutics. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tushar covering: How his opportunistic nature led him to several roles, companies and locations across the processing and biopharmaceutical sector Being given the task of building a worldwide manufacturing and suppl...
From rural roots to global pharma leader
August 18, 2023 12:17 - 48 minutes - 110 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mike Martin, Chief Executive Officer at CAI. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Mike, covering: How a passion for engineering led to a lifetime in life sciences - including 32 years with Eli Lilly Why working in China, Puerto Rico, and Ireland and the exposure to new cultures changed this ‘mid-west farm boy’s view o...
Igniting biotech innovation
August 11, 2023 11:56 - 49 minutes - 113 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kathy Fernando, Senior Vice President and Global Head of Pfizer Ignite and Pfizer CentreOne. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kathy, covering: How the forgotten step-child that is mRNA rose to the top of the technology vaccine tree Some of the key ingredients of the secret sauce that has dramatically improved the ...
From CDMO exit to CDMO+
August 04, 2023 11:26 - 46 minutes - 107 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tim Scott, President and CEO, AustinPx. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tim, covering: The founding story of Pharmatek, and how client centricity and ‘training the hell out of the team’ contributed to the growth How the niche of being a spray drying expert led to a sale of Pharmatek to Catalent... and why he did...
From MBO to global, family-run CRO
July 28, 2023 12:25 - 51 minutes - 118 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Graham Wylie, Executive Chairman at the Medical Research Network (MRN). Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Graham, covering: Transitioning from Pfizer’s in-house R&D team to a senior commercial BD role at Parexel The brutal experience of leading an MBO deal and why you should go into any deal with ‘your eyes open' ...
Attracting and retaining the best talent; a roundtable special
July 21, 2023 08:54 - 58 minutes - 134 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with: James Edgar, Chief People Officer at Sygnature Discovery Andrew Mears, CEO and Co-founder at Lead Candidate Laura Child, Head of Research and Strategy at ramarketing Your host, Raman Sehgal, discusses pharmaceutical and biotechnology talent challenges and solutions with his guests, covering: Where the industry-wide talent challenge originates, and practical sol...
Breathing life into high potential medicines
July 14, 2023 09:18 - 49 minutes - 113 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Alok Tayi, Founder and CEO at Vibe Bio. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Alok, covering: The personal story that motivated and inspired Alok to create a rare disease platform focused entirely on creating an ecosystem focused on high potential medicines. Lessons from ‘the grind’ of raising over $100m in ca...
Molecule to Market is on the move...
July 12, 2023 09:13 - 8 minutes - 20 MBIn this special episode of Molecule to Market, instead of going inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, you'll hear a special announcement about the show moving to Toronto! The announcement reveals why our show sponsor, ramarketing is opening a new office in Canada and what this means for your favorite podcast and host. Listen to the short episode to hear: About the drivers behind ramarketing's decision to establish a second off...
Barbara’s journey into Biopharma
July 07, 2023 12:19 - 51 minutes - 118 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Barbara Morgan, Global Vice-President of Pharma and Biotechnology at Kerry. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Barbara, covering: Believing in herself and being brave enough to leave a company that felt like family in a job that she loved Why Pharma has proved itself to be indispensable, while the biopharma slowd...
The CDMO CEO that doesn’t sugarcoat
June 30, 2023 06:47 - 49 minutes - 114 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Marcel Velterop, CEO and Member of the Board at Primopus. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Marcel, covering: Tips for technical people looking to transition and navigate into a commercial career path Why the CDMO business is not for the faint-hearted given the brutal focus on execution and results Insights from a...
Wheeler CDMO Avengers...assemble!
June 23, 2023 12:59 - 40 minutes - 93.2 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jesse McCool, Co-Founder and CEO at Wheeler Bio. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Jesse, covering: His journey from the Lonza bench to the boardroom as CEO of Cytovance CEO before becoming a founder Building a CDMO from a blank canvas via a pit stop of C19 testing What makes Oklahoma City an attractive place to d...
The future is bright, the future is CGT
June 16, 2023 12:12 - 49 minutes - 113 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Lung-I Cheng, Vice President of Cell & Gene Therapy at AmerisourceBergen. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Lung-I, covering: His take on the different models of healthcare he has seen globally, and the value they do and don’t deliver to patients The access, and infrastructural challenges of CGT products and ways t...
The biopharma boss on a mission against mental health disorders
June 09, 2023 10:56 - 52 minutes - 120 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Shawn Singh, Chief Executive Officer and Director at Vistagen Therapeutics. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Shawn, covering: What life is like running a public company and how that is impacted depending upon the season of the capital markets The ups, downs and pivots of a biopharmaceutical company that’s led it d...
From semiconductors to life sciences
June 02, 2023 12:13 - 49 minutes - 114 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Wayne Woodard, CEO at Argonaut Manufacturing Services. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Wayne, covering: How a career in the famously outsourced semiconductor industry benefited his route into the outsourced life science space The basic thesis that led to the start-up of Argonaut and the deliberate intention to ‘s...
The CRO scientist turned entrepreneur
May 26, 2023 13:00 - 44 minutes - 101 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Richard Weaver, Founder and Managing Director at Drug Discovery Solutions. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Richard, covering: How his curiosity to learn at AZ led him to realizing he was an entrepreneur The opportunistic start-up story and impressive growth journey of XenoGesis up to the eventual, successful sale...
CDMO poacher turned biotech gamekeeper
May 19, 2023 11:23 - 50 minutes - 117 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Vishnu Dwadasi, Director of Manufacturing at Ashvattha Therapeutics Inc. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Vishnu, covering: Lessons learned from 15 years in CDMOs and consulting, before joining a start-up drug development company What he’s learned from working with and managing CDMOs all over the world Why man...
Q123 M&A roundtable
May 12, 2023 08:53 - 56 minutes - 130 MBIn this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with: Ross Burn, Chief Executive at CatSci James Hales, Senior Director at NorthEdge Tom Cowap, Managing Director for Pharma Services at Baird Your host, Raman Sehgal, discusses pharmaceutical and biotechnology supply chain M&A activity with his guests, covering: How the market headwinds, continued consolidation and macro slowdowns are impacting M&A activity in our space.....